Company intelligence / Profile preview

GeneusDNA

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

GeneusDNA offers at-home saliva-based DNA tests that provide over 500 personalized insights related to health risks, nutrition, fitness, allergies, and talent discovery. Their reports are generated using a patented algorithm analyzing over 20,000 genes and more than 10 million genetic markers. Results are processed in CLIA-certified and CAP-accredited labs with FDA-cleared kits. The company is recognized as the leading provider of genetic tests in Southeast Asia.

Therapeutic areas: OtherMetabolic Disorders
Modalities: DNA testingGenomic analysis
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on GeneusDNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneusDNA.

Explore the full profile